ProQR Therapeutics N.V. - Ordinary Shares (PRQR): Price and Financial Metrics


ProQR Therapeutics N.V. - Ordinary Shares (PRQR)

Today's Latest Price: $3.83 USD

0.08 (-2.05%)

Updated Oct 29 1:00pm

Add PRQR to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 384 in Biotech

See all "A" rated Strong Buy stocks

PRQR Stock Summary

  • PRQR's price/sales ratio is 90.56; that's higher than the P/S ratio of 97.12% of US stocks.
  • With a year-over-year growth in debt of 175.06%, ProQR Therapeutics NV's debt growth rate surpasses 91.51% of about US stocks.
  • As for revenue growth, note that PRQR's revenue has grown -41.35% over the past 12 months; that beats the revenue growth of just 5.91% of US companies in our set.
  • Stocks that are quantitatively similar to PRQR, based on their financial statements, market capitalization, and price volatility, are AUTL, DNLI, AGIO, FATE, and RGNX.
  • Visit PRQR's SEC page to see the company's official filings. To visit the company's web site, go to www.proqr.com.

PRQR Stock Price Chart Interactive Chart >

Price chart for PRQR

PRQR Price/Volume Stats

Current price $3.83 52-week high $10.98
Prev. close $3.91 52-week low $3.76
Day low $3.76 Volume 57,737
Day high $3.99 Avg. volume 182,395
50-day MA $4.90 Dividend yield N/A
200-day MA $5.77 Market Cap 192.05M

ProQR Therapeutics N.V. - Ordinary Shares (PRQR) Company Bio


ProQR Therapeutics is a biopharmaceutical company, focused on RNA medicines for the treatment of severe diseases such as cystic fibrosis and Leber's congenital amaurosis. The company was founded in 2012 and is based in Leiden, the Netherlands.


PRQR Latest News Stream


Event/Time News Detail
Loading, please wait...

PRQR Latest Social Stream


Loading social stream, please wait...

View Full PRQR Social Stream

Latest PRQR News From Around the Web

Below are the latest news stories about ProQR Therapeutics NV that investors may wish to consider to help them evaluate PRQR as an investment opportunity.

Usher Syndrome Type 2 Treatment Market Outlook and Forecast Report By ProQR Therapeutics, Editas Medicine, Nobelpharma Co., Ltd, Sensorion, Advanced Bionics AG

The company profiles of all the key players and brands that are dominating the Usher Syndrome Type 2 Treatment Market have been taken into consideration here. The report has wide-ranging and comprehensive market insights which are based on business intelligence. This Global Usher

OpenPR | September 30, 2020

ProQR Therapeutics Is A Worthy Play

Morality is simply the attitude we adopt towards people we personally dislike.”― Oscar Wilde Today, we revisit an intriguing name for the first time in approximately one year. The company has made good progress developing its pipeline even as its stock has declined. It now has a compelling risk/reward profile....

Busted IPO Forum on Seeking Alpha | September 14, 2020

ProQR Therapeutics: Bringing A New Cure To The Market

Introduction While ProQR’s (PRQR) share price experienced an unpredicted run in 2018, it has now been back to the previous level. ProQR is a small company that focuses on developing drugs for a small number of patients with rare diseases. For example, it offers unique solutions for patients with inherited...

Tien Duy Vo on Seeking Alpha | August 31, 2020

Analysts Are Betting On ProQR Therapeutics N.V. (NASDAQ:PRQR) With A Big Upgrade This Week

Celebrations may be in order for ProQR Therapeutics N.V. (NASDAQ:PRQR) shareholders, with the analysts delivering a...

Yahoo | July 23, 2020

ProQR Strengthens Scientific Advisory Board with Leaders in Inherited Retinal Disease and RNA Therapy

LEIDEN, Netherlands & CAMBRIDGE, Mass., July 21, 2020 -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative.

Yahoo | July 21, 2020

Read More 'PRQR' Stories Here

PRQR Price Returns

1-mo -20.54%
3-mo -25.92%
6-mo -21.68%
1-year -43.09%
3-year -0.52%
5-year -73.71%
YTD -61.35%
2019 -37.20%
2018 389.30%
2017 -34.18%
2016 -43.55%
2015 -59.94%

Continue Researching PRQR

Here are a few links from around the web to help you further your research on ProQR Therapeutics NV's stock as an investment opportunity:

ProQR Therapeutics NV (PRQR) Stock Price | Nasdaq
ProQR Therapeutics NV (PRQR) Stock Quote, History and News - Yahoo Finance
ProQR Therapeutics NV (PRQR) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8447 seconds.